Pearce Samantha
EVP, Chief Commercial Officer
Pearce Samantha has filed 6 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2026. 6 of those filings fall inside the rolling window. Most recent filing: Aug 7, 2026.
On the most recent filing, Pearce Samantha is listed as EVP, Chief Commercial Officer at Jazz Pharmaceuticals plc. Inside the rolling window, Pearce Samantha reported no open-market purchases and 1 open-market sale totaling $1.6M in JAZZ.
Companies traded
Other insiders at JAZZ
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Pearce Samantha made?
Pearce Samantha has filed 6 SEC Form 4 filings (8 transaction rows) across 1 company since 2026.
Which companies does Pearce Samantha trade?
Pearce Samantha has filed SEC Form 4 disclosures for 1 company, including JAZZ.
When was Pearce Samantha's most recent SEC Form 4 filing?
Pearce Samantha's most recent SEC Form 4 filing on Tracefour is dated Aug 7, 2026.
What is Pearce Samantha's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Pearce Samantha is listed as EVP, Chief Commercial Officer.
What is Pearce Samantha's total buy and sell value in the current window?
Inside the rolling retention window, Pearce Samantha bought $0 and sold $1.6M based on SEC Form 4 filings.
What was Pearce Samantha's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,907 JAZZ shares on 2026-05-28, worth $1.6M, per SEC Form 4 filings.